News > Biological E's Covid-19 vaccine 'Corbevax' receives emergency use approval for 12-18 age group
Biological E's Covid-19 vaccine 'Corbevax' receives emergency use approval for 12-18 age group
The Free Press Journal | 21/02/2022 08:25 PM | Click to read full article
The Drugs Controller General of India (DCGI) on Monday gave an emergency use nod to Hyderabad-based pharmaceutical company Biological E's Coronavirus vaccine ‘Corbevax’ for children aged 12-18 years.
This is the third vaccine approved for use in children aged 12 and above in India, joining Zydus Cadila's DNA shot ZyCoV-D and Bharat Biotech's Covaxin.
